These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22360920)

  • 1. Cardiovascular risk and combined oral contraceptives: clinical decisions in settings of uncertainty.
    Beller JP; McCartney CR
    Am J Obstet Gynecol; 2013 Jan; 208(1):39-41. PubMed ID: 22360920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular events associated with different combined oral contraceptives: a review of current data.
    Hannaford P
    Drug Saf; 2000 May; 22(5):361-71. PubMed ID: 10830253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk and the use of oral contraceptives.
    Kaminski P; Szpotanska-Sikorska M; Wielgos M
    Neuro Endocrinol Lett; 2013; 34(7):587-9. PubMed ID: 24464000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal contraception--what kind, when, and for whom?
    Wiegratz I; Thaler CJ
    Dtsch Arztebl Int; 2011 Jul; 108(28-29):495-505; quiz 506. PubMed ID: 21814535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimising risk in contraception.
    Tate P
    Practitioner; 1997 Oct; 241(1579):571-4, 576, 580. PubMed ID: 9926590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-free oral hormonal contraception: benefits of the progestin-only pill.
    de Melo NR
    Womens Health (Lond); 2010 Sep; 6(5):721-35. PubMed ID: 21080791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and risks of oral contraceptives.
    Drife J
    Adv Contracept; 1990 Dec; 6 Suppl():15-25. PubMed ID: 2291444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular risks associated with low-dose combined oral contraceptives].
    Merki-Feld GS
    Ther Umsch; 2001 Sep; 58(9):564-9. PubMed ID: 11594156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects on mortality of the use of combined oral contraceptives.
    Oldfield K; Milne R; Vessey M
    Br J Fam Plann; 1998 Apr; 24(1):2-6. PubMed ID: 9719700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome.
    Soares GM; Vieira CS; de Paula Martins W; Dos Reis RM; de Sá MF; Ferriani RA
    Int J Clin Pract; 2009 Jan; 63(1):160-9. PubMed ID: 18795969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined oral contraceptive use among women with hypertension: a systematic review.
    Curtis KM; Mohllajee AP; Martins SL; Peterson HB
    Contraception; 2006 Feb; 73(2):179-88. PubMed ID: 16413848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female sexual dysfunction with combined oral contraceptive use.
    Lee JJ; Tan TC; Ang SB
    Singapore Med J; 2017 Jun; 58(6):285-288. PubMed ID: 28642961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraception and cardiovascular disorders.
    Gupta S; Harding K
    Br J Fam Plann; 1999 Apr; 25(1):13-7. PubMed ID: 10228244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic and cardiovascular risks of women on combined oral contraceptives: A comparative study.
    Jimoh OS; Abdul IF; Balogun OR; Biliaminu SA; Adeniran AS; Jimoh-Abdulghaffaar HO; Adesina KT; Ahmed A; Oladosu WO
    Niger J Clin Pract; 2021 Dec; 24(12):1759-1765. PubMed ID: 34889782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined oral contraception and the risk of reproductive organs cancer in women].
    Medard M L; Ostrowska L
    Ginekol Pol; 2007 Aug; 78(8):637-41. PubMed ID: 18050614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
    Samuelsson E; Hägg S
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden carriers taking oral contraceptives have an increased risk of thrombosis.
    Aznar J; Cerdá G
    Am J Obstet Gynecol; 2013 Aug; 209(2):156. PubMed ID: 23453804
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO scientific group meeting on cardiovascular disease and steroid hormone contraceptives.
    Wkly Epidemiol Rec; 1997 Nov; 72(48):361-3. PubMed ID: 9409187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.